Speaker Details

Ana M Gimenez-Arnau, MD, IFAAD

Ana M Gimenez-Arnau, MD, IFAAD

SESSIONS

F083 Chronic Urticaria: What's New
Mar 10, 2025 9:00 AM - 11:00 AM W207A

DISCLOSURES

Almirall – Advisory Board(Fees); Amgen – Advisory Board(Fees); AstraZeneca – Investigator(Grants/Research Funding); Avene – Speaker(Fees); Blueprint Medicines – Advisory Board(Fees); Celldex – Investigator(Grants/Research Funding); Escient – Investigator(Grants/Research Funding); Genentech – Investigator(Grants/Research Funding); Grupo Menarini Centroamerica – Speaker(Fees); GSK – Advisory Board(Fees); Instituto de Salud Carlos III – Investigator(Grants/Research Funding); Jasper Therapeutics – Advisory Board(Fees); Leo Pharma – Investigator(Grants/Research Funding); Mitsubishi Tanabe Pharma Development America – Advisory Board(Fees); Noucor, – Advisory Board(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi–Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Septerna – Advisory Board(Fees); Servier – Advisory Board(Fees);